EGFR and non-small cell lung carcinoma: A positive baseline ctDNA level has also been identified as an independent risk factor for disease-free survival (DFS), along with stage and micropapillary subtype, in patients with curatively resected EGFR-mutated stage I–IIIA NSCLC [18].